Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
As such, GLP-1 has been studied as a potential therapeutic for the treatment and management of high-impact neurodegenerative disorders, namely Alzheimers disease (AD) and Parkinsons disease (PD)
Strong indicators that you are ready for the next dose step include: GI side effects have fully resolved at the current dose Appetite suppression has stabilized (not increasing or decreasing week to week) Weight loss has slowed or plateaued at the current dose Energy levels are stable and consistent Sleep quality has returned to baseline Indicators that you should hold at the current dose for another cycle include: Persistent nausea beyond the first week at the current dose Digestive issues that have not resolved Weight loss is still progressing well (no need to increase if current dose is working) Energy levels are still adjusting Any concerning symptoms that need medical evaluation The tracking data also helps identify your optimal maintenance dose
Always consult your physician before beginning any treatment or therapy program
The slowed digestion is real
